The adult patient with eisenmenger syndrome: A medical update after dana point part III: Specific management and surgical aspects

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 363-372

  Oechslin, Erwin ^a   Mebus, Siegrun ^b   Schulze Neick, Ingram ^c   Niwa, Koichiro ^d   Trindade, Pedro T ^e   Eicken, Andreas ^b   Hager, Alfred ^b   Lang, Irene ^f   Hess, John ^b   Kaemmerer, Harald ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d CHIBA CARDIOVASCULAR CENTER   (Japan)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adult congenital heart defects; Cardiovascular diseases; Competence Network for Congenital Heart Defects; Eisenmenger syndrome; Followup studies; Pulmonary hypertension

Indexed keywords

ALLOPURINOL; BOSENTAN; COLCHICINE; CORTICOSTEROID; DESOGESTREL; DIGOXIN; DIURETIC AGENT; ETONOGESTREL; GESTAGEN; GLUCOSE; HEPARIN; HYPERTENSIVE FACTOR; ILOPROST; IRON; LEVONORGESTREL; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE; PROBENECID; PROSTAGLANDIN; SALSALATE; URICOSURIC AGENT;

ADULT; ALTITUDE; ARTICLE; ATOPY; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD VISCOSITY; CEREBROVASCULAR DISEASE; CHOLELITHIASIS; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CONTRACEPTION; EISENMENGER COMPLEX; ERYTHROCYTOSIS; GLANZMANN DISEASE; GLUCOSE BLOOD LEVEL; GOUT; HEMATOCRIT; HEMOPTYSIS; HUMAN; HYPERVISCOSITY SYNDROME; HYPOTENSION; IRON DEFICIENCY; IRON THERAPY; KIDNEY DYSFUNCTION; LUNG ARTERY BANDING; MEDICAL INFORMATION; OSTEOARTHROPATHY; OUTCOME ASSESSMENT; PARADOXICAL EMBOLISM; PARAMETER; PATIENT REFERRAL; PHLEBOTOMY; PHYSICIAN; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; THROMBOSIS; TRANSPLANTATION; TRAVEL; TREATMENT OUTCOME;

EID: 78651289927     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566127     Document Type: Article

References (63)

1. Diller GP, Dimopoulos K, Broberg CS, et al. Presentation, survivalprospects, and predictors of death in Eisenmenger syndrome: acombined retrospective and case-control study. Eur Heart J 2006; 27(14): 1737-42.
2. Broberg CS, Bax BE, Okonko DO, et al. Blood viscosity and itsrelationship to iron deficiency, symptoms, and exercise capacity inadults with cyanotic congenital heart disease. J Am Coll Cardiol 2006; 48(2): 356-65.
3. Wells R. Syndromes of hyperviscosity. N Engl J Med 1970; 283(4): 183-6.
4. Perloff J, Child J, Aboulhosn J. Cyanotic congenital heart disease: amultisystem disorder. Congenital heart disease in adults. 3rd ed:Elsevier, Saunders 2009; pp. 265-89.
5. Oechslin E, Kiowski W, Schindler R, Bernheim A, Julius B, Brunner-La Rocca HP. Systemic endothelial dysfunction in adultswith cyanotic congenital heart disease. Circulation. 2005; 112(8): 1106-12.
6. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensatederythrocytosis in cyanotic congenital heart disease. Lancet 1986; 2(8502): 313-5.
7. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanoticcongenital heart disease: hematologic management. Ann InternMed 1988; 109(5): 406-13.
8. Oechslin E. Eisenmenger syndrome. In:, Gatzoulis MA, Webb GD, Daubepey PEF, Ed. Diagnosis and management of adult congenitalheart disease. Churchill Livingstone 2003; pp. 363-77.
9. Oechslin E. Hematological management of the cyanotic adult withcongenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 109-15.
10. Strumia MM. Modern clinical aspects of blood transfusion. Panminerva Med 1963; 5: 184-6.
11. Card RT, Weintraub LR. Metabolic abnormalities of erythrocytesin severe iron deficiency. Blood 1971; 37(6): 725-32.
12. Tillmann W, Schroter W. Deformability of erythrocytes in irondeficiency anemia. Blut 1980; 40(3): 179-86.
13. Milligan DW, MacNamee R, Roberts BE, Davies JA. The influenceof iron-deficient indices on whole blood viscosity inpolycythaemia. Br J Haematol 1982; 50(3): 467-71.
14. Pearson TC, Grimes AJ, Slater NG, Wetherley-Mein G. Viscosityand iron deficiency in treated polycythaemia. Br J Haematol 1981; 49(1): 123-7.
15. Van de Pette JE, Guthrie DL, Pearson TC. Whole blood viscosity inpolycythaemia: the effect of iron deficiency at a range ofhaemoglobin and packed cell volumes. Br J Haematol 1986; 63(2): 369-75.
16. Reinhart WH. The influence of iron deficiency on erythrocytedeformability. Br J Haematol 1992; 80(4): 550-5.
17. Silber MH, Richardson JW. Multiple blood donations associatedwith iron deficiency in patients with restless legs syndrome. MayoClin Proc 2003; 78(1): 52-4.
18. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrinin restless legs syndrome. Neurology 2000; 54(8): 1698-700.
19. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. TheEisenmenger syndrome in adults. Ann Intern Med 1998; 128(9): 745-55.
20. Silversides CK, Salehiam O, Oechslin E, et al. Canadian CardiovascularSociety 2009 Consensus Conference on the managementof adult congenital heart disease: complex congenital cardiac lesions. Can J Cardiol 2010; 26(3): e98-e117.
21. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008guidelines for the management of adults with congenital heart disease:a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines (WritingCommittee to Develop Guidelines on the Management of AdultsWith Congenital Heart Disease). J Am Coll Cardiol 2008; 52(23): e1-e121.
22. Ammash N, Warnes CA. Cerebrovascular events in adult patientswith cyanotic congenital heart disease. J Am Coll Cardiol 1996Sep; 28(3): 768-72.
23. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults withcyanotic congenital heart disease. Circulation 1993; 87(6): 1954-9.
24. Oldershaw PJ, Sutton MG. Haemodynamic effects of haematocritreduction in patients with polycythaemia secondary to cyanoticcongenital heart disease. Br Heart J 1980; 44(5): 584-8.
25. Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS. Acute hemodynamic effects of red cell volumereduction in polycythemia of cyanotic congenital heart disease. Circulation 1970; 42(2): 297-308.
26. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia incyanotic congenital heart disease. Am J Cardiol 2006; 98(2): 254-8.
27. Waldman JD, Czapek EE, Paul MH, Schwartz AD, Levin DL, Schindler S. Shortened platelet survival in cyanotic heart disease. JPediatr 1975; 87(1): 77-9.
28. Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects incyanotic congenital heart disease. Br Heart J 1979; 41(1): 23-7.
29. Wedemeyer AL, Edson JR, Krivit W. Coagulation in cyanoticcongenital heart disease. Am J Dis Child 1972; 124(5): 656-60.
30. Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmengersyndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999; 34(1): 223-32.
31. Daliento L, Somerville J, Presbitero P, et al. Eisenmengersyndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19(12): 1845-55.
32. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximalpulmonary arterial and intrapulmonary radiologic features ofEisenmenger syndrome and primary pulmonary hypertension. Am JCardiol 2003; 92(2): 182-7.
33. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmengersyndrome. J Am Coll Cardiol 2003; 42(11): 1982-7.
34. Broberg CS, Ujita M, Prasad S, et al. Pulmonary arterial thrombosisin eisenmenger syndrome is associated with biventriculardysfunction and decreased pulmonary flow velocity. J Am CollCardiol 2007; 50(7): 634-42.
35. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacingleads and systemic thromboemboli in patients with intracardiacshunts: a multicenter study. Circulation 2006; 113(20): 2391-7.
36. O'Byrne S, Shirodaria C, Millar T, Stevens C, Blake D, Benjamin N. Inhibition of platelet aggregation with glyceryl trinitrate andxanthine oxidoreductase. J Pharmacol Exp Ther 2000; 292(1): 326-30.
37. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenitalheart disease. Circulation 2008; 117(18): 2320-8.
38. Burlet A, Drukker A, Guignard JP. Renal function in cyanoticcongenital heart disease. Nephron 1999; 81(3): 296-300.
39. Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants ofsurvival and length of survival in adults with Eisenmengersyndrome. Am J Cardiol 1999; 84(6): 677-81.
40. Wood P. The Eisenmenger syndrome or pulmonary hypertensionwith reversed central shunt. Br Med J 1958; 2(5099): 755-62.
41. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000; 86(10): 1111-6.
42. Ross EA, Perloff JK, Danovitch GM, Child JS, Canobbio MM. Renal function and urate metabolism in late survivors with cyanoticcongenital heart disease. Circulation 1986; 73(3): 396-400.
43. Perloff JK. Systemic complications of cyanosis in adults withcongenital heart disease. Hematologic derangements, renalfunction, and urate metabolism. Cardiol Clin 1993; 11(4): 689-99.
44. Oya H, Nagaya N, Satoh T et al. Haemodynamic correlates andprognostic significance of serum uric acid in adult patients withEisenmenger syndrome. Heart 2000; 84(1): 53-8.
45. Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adultswith cyanotic congenital heart disease. Circulation 1996; 93(2): 272-6.
46. Broberg CS, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome reportflying safely on commercial airlines. Heart 2007; 93(12): 1599-603.
47. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infectiveendocarditis: guidelines from the American Heart Association: aguideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council onCardiovascular Disease in the Young, and the Council on ClinicalCardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research InterdisciplinaryWorking Group. Circulation 2007; 116(15): 1736-54.
48. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version2009): the Task Force on the Prevention, Diagnosis, and Treatmentof Infective Endocarditis of the European Society of Cardiology(ESC). Eur Heart J 2009; 30(19): 2369-413.
49. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger'ssyndrome and pregnancy. Obstet Gynecol Surv 1979; 34(10): 721-41.
50. Avila WS, Grinberg M, Snitcowsky R, et al. Maternal and fetaloutcome in pregnant women with Eisenmenger's syndrome. EurHeart J 1995; 16(4): 460-4.
51. Kiely D, Elliot C, Webster V, Stewart P. Pregnancy and pulmonaryhypertension: new approaches to the management of a lifethreateningcondition. In: Steer PJ GM, Baker P, editor. Heart Disease and Pregnancy. London: RCOG Press; 2006; pp. 211-29.
52. Dhanjal M. Contraception in women with heart disease In: Steer PJ, Gatzoulis MA, P B, editors. Heart Disease and Pregnancy. London:RCOG Press; 2006; pp. 9-26.
53. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy andcongenital heart disease. BMJ 2006; 332(7538): 401-6.
54. Perloff J, Sopher M. Noncardiac surgery. In: Perloff J, Child J, Aboulhosn J, Eds. Congenital Heart Disease in Adults. 3rd ed:Saunders / Elsevier; 2009; pp. 380-9.
55. Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiacsurgery in Eisenmenger syndrome. J Am Coll Cardiol 1999; 33(1): 222-7.
56. Batista RJ, Santos JL, Takeshita N, et al. Successful reversal ofpulmonary hypertension in Eisenmenger complex. Arq BrasCardiol 1997; 68(4): 279-80.
57. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparisonof the hemodynamics and survival of adults with severe primarypulmonary hypertension or Eisenmenger syndrome. J Heart LungTransplant 1996; 15(1 Pt 1): 100-5.
58. Oya H, Nagaya N, Uematsu M, et al. Poor prognosis and relatedfactors in adults with Eisenmenger syndrome. Am Heart J 2002; 143(4): 739-44.
59. Goerler H, Simon A, Gohrbandt B, et al. Heart-lung and lungtransplantation in grown-up congenital heart disease: long-termsingle centre experience. Eur J Cardiothorac Surg 2007; 32(6): 926-31.
60. Ueno T, Smith JA, Snell GI, et al. Bilateral sequential single lungtransplantation for pulmonary hypertension and Eisenmenger'ssyndrome. Ann Thorac Surg 2000; 69(2): 381-7.
61. Choong CK, Sweet SC, Guthrie TJ, et al. Repair of congenital heartlesions combined with lung transplantation for the treatment ofsevere pulmonary hypertension: a 13-year experience. J ThoracCardiovasc Surg 2005; 129(3): 661-9.
62. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. JHeart Lung Transplant 2002; 21(7): 731-7.
63. Stoica SC, McNeil KD, Perreas K, et al. Heart-lung transplantationfor Eisenmenger syndrome: early and long-term results. AnnThorac Surg 2001; 72(6): 1887-91.